Relationship between single nucleotide polymorphisms of paraoxonase 2 and stroke

Chinese Journal of Medical Genetics

Volumn 24, Issue 3, 2007, Pages 328-330

  Xu, Hong Wei ^a   Zhao, Zhen ^a   Yuan, Ning ^a   Xiao, Bo ^a   Yang, Xiao Su ^a   Tang, Bei Sha ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cerebral hemorrhage; Cerebral infarction; Genetic polymorphism; Paraoxonase 2

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 2; UNCLASSIFIED DRUG;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGED; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 34250801496     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ng CJ, Wadleigh DJ, Gangopadhyay A, et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of lowdensity lipoprotein. J Biol Chem, 2001, 276:44444-44449.
2. Rosenblat M, Draganov D, Watson CE, et al. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonas3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol, 2003, 23: 468-474.
3. Zhao WJ, Yang HP, Shen YF, et al. Study on the association between paraoxponase 2 gene C311S and cerebral infarction. Chin J Geratol, 2005, 25:117-119.
4. Wang XY, Xue YM, Wen SJ, et al. The association of araoxponase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients. Chin J Med Genet, 2003, 20:215-219.
5. Hao YL, Lin LX, Chen G, et al. Relationship between paraoxonase 2 A148G polymorphism and diabetic nephropathy. Chin J Nephrol, 2002, 18:422-424.
6. Primo-Panno SL, Sorenson RC, Teiber J, et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigenefamily. Genomics, 1996, 33:498-507.
7. Rosenblat M, Draganov D, Watson CE, et al. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol, 2003, 23: 468-474;
8. Arterioscler Thromb Vasc Biol, 2002, 22:1329-1333.
9. Shiner M, Fuhrman B, Aviram M. Paraoxonase(PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinuoleotide-phosphat-e (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. Free Radic Biol Med, 2004, 37:2052-2063.
10. Rosenblat M, Hayek T, Hussein K, et al. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler Thromb Vasc Biol, 2004, 24:175-180.
11. Imai Y, Morita H, Knrihara H, et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis, 2000, 149:435-442.
12. Ranade K, Kirchgessner TG, Iakoubova OA, et al. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke, 2005, 36:2346-2350.